Surgery Partners, Inc. SGRY

Set alert

Price alert · SGRY

All alert types
23.12 USD -0.09 -0.39%

At close

23.10 -0.02 -0.09%

Pre-market · Nov 3, 7:05 AM ET

Bid
23.13 × 2
Ask
23.15 × 1
23.12 Day range 23.23
11.41 52-week range 23.37
YTD
+49.64%
1 year
+6.54%
Open
23.21
Prev close
23.21
Mkt cap
2.98B
Vol
3.40M
Avg vol
3.40M
EPS
-0.69
P/E
0.00
Div yield
0.00%
More statistics
Low
23.12
High
23.23
Forward P/E
111.07
Beta
1.88
Short ratio
6.88
Inst. own
128.71%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
15.13
200-d avg
14.63
1y target
21.70

5D chart

Chart tools
Interval

Events in this range
  • Oct 27, 2026Downgrade: StoneX · Buy → Hold
  • Oct 28, 2026Downgrade: UBS · Buy → Neutral
Signals (60)
NameTimeAgo
MACD: Sell SignalNov 2, 3:10 PM16 hours ago
MACD: Buy SignalNov 2, 2:15 PM17 hours ago
MACD: Sell SignalNov 2, 12:30 PM18 hours ago
SMA: BullishNov 2, 11:55 AM19 hours ago
MACD: Buy SignalNov 2, 11:40 AM19 hours ago
MACD: Sell SignalNov 2, 11:00 AM20 hours ago
SMA: BearishNov 2, 10:30 AM20 hours ago
SMA: BullishNov 2, 10:25 AM21 hours ago
MACD: Buy SignalNov 2, 10:25 AM21 hours ago
SMA: BullishNov 2, 10:10 AM21 hours ago
SMA: BearishNov 2, 9:35 AM21 hours ago
MACD: Sell SignalNov 2, 9:35 AM21 hours ago
MACD: Buy SignalOct 30, 3:05 PM3 days ago
MACD: Sell SignalOct 30, 2:30 PM3 days ago
MACD: Buy SignalOct 30, 2:00 PM3 days ago
SMA: BullishOct 30, 1:50 PM3 days ago
MACD: Sell SignalOct 30, 12:45 PM3 days ago
SMA: BearishOct 30, 12:40 PM3 days ago
MACD: Buy SignalOct 30, 11:20 AM3 days ago
SMA: BullishOct 30, 11:10 AM3 days ago

Newest 20 of 60.

Analyst view

Consensus: buy

Buy
Price target (mean) 21.70 -6.1% downside
Target (low)
19.00
Target (mean)
21.70
Target (high)
23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold5
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 12
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SGRY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.124670.07 – 0.200.13-4.1%814.70M-0.8%5
Next quarter0.154860.02429 – 0.330.12+29.0%680.50M-23.1%5
Current year0.355960.21981 – 0.600.47-24.3%3.15B-4.7%5
Next year0.208150.03 – 0.430.35596-41.5%2.80B-11.2%5

Upgrades and downgrades

The latest rating changes

SGRY analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026UBSDowngradeBuyNeutral
Oct 27, 2026StoneXDowngradeBuyHold
Sep 30, 2026RBC CapitalReiteratedOutperformOutperform
Sep 18, 2026TD CowenReiteratedBuyBuy
Sep 14, 2026JP MorganMaintainedNeutralNeutral
Aug 11, 2026TD CowenMaintainedBuyBuy
Aug 11, 2026RBC CapitalMaintainedOutperformOutperform
Aug 11, 2026Cantor FitzgeraldReiteratedOverweightOverweight
Mar 5, 2026TD CowenMaintainedBuyBuy
Mar 5, 2026UBSMaintainedBuyBuy
Mar 5, 2026MizuhoMaintainedOutperformOutperform
Mar 4, 2026RBC CapitalMaintainedOutperformOutperform
Mar 3, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Dec 18, 2025MizuhoMaintainedOutperformOutperform
Nov 24, 2025JP MorganMaintainedNeutralNeutral
Nov 21, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Nov 17, 2025MizuhoMaintainedOutperformOutperform
Nov 13, 2025UBSMaintainedBuyBuy
Nov 11, 2025RBC CapitalMaintainedOutperformOutperform
Nov 11, 2025BenchmarkMaintainedBuyBuy
Oct 7, 2025Cantor FitzgeraldReiteratedOverweightOverweight
May 27, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Apr 21, 2025BenchmarkReiteratedBuyBuy
Mar 25, 2025RBC CapitalReiteratedOutperformOutperform
Mar 11, 2025MacquarieMaintainedOutperformOutperform
Dec 3, 2024JP MorganMaintainedNeutralNeutral
Nov 20, 2024RBC CapitalMaintainedOutperformOutperform
Nov 19, 2024MacquarieMaintainedOutperformOutperform
Nov 13, 2024MacquarieMaintainedOutperformOutperform
Nov 4, 2024MacquarieMaintainedOutperformOutperform